Atlas Trials

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Clinical trial NCT02832037 · COMPLETED

Trial details

NCT number
NCT02832037
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2016-07-25
Primary completion
2019-12-27
Enrollment
509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.